Latest Articles

Publication Date
All News Scientific
HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer - Yahoo Canada Finance

HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer Yahoo Canada Finance

Published: Dec. 3, 2024, 10 a.m.
Read Full Article
HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer - Yahoo Finance

HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer Yahoo Finance

Published: Dec. 3, 2024, 10 a.m.
Read Full Article
HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer - Yahoo Finance UK

HUTCHMED and Innovent Jointly Announce NMPA Conditional Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Advanced Endometrial Cancer Yahoo Finance UK

Published: Dec. 3, 2024, 10 a.m.
Read Full Article
Is Your Drinking Water Safe? This Metal In Your Supply May Pose Cancer Risk - Medical Daily

Is Your Drinking Water Safe? This Metal In Your Supply May Pose Cancer Risk Medical Daily

Published: Dec. 3, 2024, 9:21 a.m.
Read Full Article
Study identifies key risk factors for recurrence in early endometrial cancer after hormonal therapy - KBR

Study identifies key risk factors for recurrence in early endometrial cancer after hormonal therapy KBR

Published: Dec. 3, 2024, 6:49 a.m.
Read Full Article
The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome - ResearchGate

The prognostic value of tumor microenvironment in endometrioid type endometrial cancer: Effect of CD44 on oncologic outcome ResearchGate

Published: Dec. 3, 2024, 6:33 a.m.
Read Full Article
Exploring Treatment Options Through Genomic Sequencing in Endometrial Cancer - Cancer Network

Exploring Treatment Options Through Genomic Sequencing in Endometrial Cancer Cancer Network

Published: Dec. 2, 2024, 7:02 p.m.
Read Full Article
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - Physician's Weekly

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers Physician's Weekly

Published: Nov. 30, 2024, 10:44 a.m.
Read Full Article
Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers - 2 Minute Medicine

Endometriosis and uterine fibroids associated with a greater risk of mortality due to gynecologic cancers 2 Minute Medicine

Published: Nov. 30, 2024, 12:15 a.m.
Read Full Article
Polish researchers develop diagnostic panel for lung, breast cancer - Polskie Radio

Polish researchers develop diagnostic panel for lung, breast cancer Polskie Radio

Published: Nov. 29, 2024, 10:30 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!